SELLAS Life Sciences Group (SLS) Cash from Operations: 2011-2024
Historic Cash from Operations for SELLAS Life Sciences Group (SLS) over the last 7 years, with Sep 2024 value amounting to -$7.8 million.
- SELLAS Life Sciences Group's Cash from Operations fell 13.26% to -$7.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$33.1 million, marking a year-over-year decrease of 4.21%. This contributed to the annual value of -$35.4 million for FY2024, which is 12.71% down from last year.
- According to the latest figures from Q3 2024, SELLAS Life Sciences Group's Cash from Operations is -$7.8 million, which was up 19.38% from -$9.7 million recorded in Q2 2024.
- Over the past 5 years, SELLAS Life Sciences Group's Cash from Operations peaked at $3.4 million during Q4 2020, and registered a low of -$12.1 million during Q1 2023.
- Moreover, its 3-year median value for Cash from Operations was -$7.2 million (2022), whereas its average is -$7.6 million.
- Per our database at Business Quant, SELLAS Life Sciences Group's Cash from Operations tumbled by 245.33% in 2021 and then soared by 30.37% in 2022.
- Over the past 5 years, SELLAS Life Sciences Group's Cash from Operations (Quarterly) stood at $3.4 million in 2020, then tumbled by 245.33% to -$5.0 million in 2021, then fell by 3.54% to -$5.2 million in 2022, then increased by 6.35% to -$4.8 million in 2023, then fell by 13.26% to -$7.8 million in 2024.
- Its last three reported values are -$7.8 million in Q3 2024, -$9.7 million for Q2 2024, and -$10.8 million during Q1 2024.